Skip to main content
Erschienen in: Indian Journal of Pediatrics 10/2020

11.02.2020 | Review Article

Influenza

verfasst von: Dhanya Dharmapalan

Erschienen in: Indian Journal of Pediatrics | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less expensive and more reliable point-of-care test for use in developing countries, to produce more efficacious antiviral drugs, to explore ways to combat emerging antiviral resistance and to develop vaccines that can either be produced in a shorter production time or can overcome the need for annual matching with the circulating influenza strains. Most importantly for India, as a nation that suffered the highest mortality in the influenza pandemic 1918, there is an urgent need to gear up our existing preparedness for the next pandemic which is capable to hit at any moment in time.
Literatur
1.
Zurück zum Zitat Chandra S, Eva K-NE. The evolution of pandemic influenza: evidence from India, 1918–19. BMC Infect Dis. 2014;14:510.CrossRef Chandra S, Eva K-NE. The evolution of pandemic influenza: evidence from India, 1918–19. BMC Infect Dis. 2014;14:510.CrossRef
2.
Zurück zum Zitat Jester B, Uyeki T, Jernigan D. Readiness for responding to a severe pandemic 100 years after 1918. Am J Epidemiol. 2018;187:2596–602.PubMedPubMedCentral Jester B, Uyeki T, Jernigan D. Readiness for responding to a severe pandemic 100 years after 1918. Am J Epidemiol. 2018;187:2596–602.PubMedPubMedCentral
3.
Zurück zum Zitat Lowen AC, Steel J. Roles of humidity and temperature in shaping influenza seasonality. J Virol. 2014;88:7692–5.CrossRef Lowen AC, Steel J. Roles of humidity and temperature in shaping influenza seasonality. J Virol. 2014;88:7692–5.CrossRef
4.
Zurück zum Zitat Ng S, Gordon A. Influenza burden and transmission in the tropics. Curr Epidemiol Rep. 2015;2:89–100.CrossRef Ng S, Gordon A. Influenza burden and transmission in the tropics. Curr Epidemiol Rep. 2015;2:89–100.CrossRef
6.
Zurück zum Zitat Chadha MS, Potdar VA, Saha S, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PLoS One. 2015;10:e0124122.CrossRef Chadha MS, Potdar VA, Saha S, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PLoS One. 2015;10:e0124122.CrossRef
7.
Zurück zum Zitat Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094–101.CrossRef Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094–101.CrossRef
8.
Zurück zum Zitat A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ. 1980;58:585–91. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ. 1980;58:585–91.
9.
Zurück zum Zitat Kumlin U, Olofsson S, Dimock K, Arnberg N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir Viruses. 2008;2:147–54.CrossRef Kumlin U, Olofsson S, Dimock K, Arnberg N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir Viruses. 2008;2:147–54.CrossRef
10.
Zurück zum Zitat Mansfield KG. Viral tropism and the pathogenesis of influenza in the Mammalian host. Am J Pathol. 2007;171:1089–92. Mansfield KG. Viral tropism and the pathogenesis of influenza in the Mammalian host. Am J Pathol. 2007;171:1089–92.
11.
Zurück zum Zitat Camp JV, Bagci U, Chu YK, et al. Lower respiratory tract infection of the ferret by 2009 H1N1 pandemic influenza A virus triggers biphasic, systemic, and local recruitment of neutrophils. J Virol. 2015;89:8733–48. Camp JV, Bagci U, Chu YK, et al. Lower respiratory tract infection of the ferret by 2009 H1N1 pandemic influenza A virus triggers biphasic, systemic, and local recruitment of neutrophils. J Virol. 2015;89:8733–48.
12.
Zurück zum Zitat Herold S, Becker C, Ridge KM, Budinger GR. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45:1463–78.CrossRef Herold S, Becker C, Ridge KM, Budinger GR. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45:1463–78.CrossRef
13.
Zurück zum Zitat Wikramaratna PS, Sandeman M, Recker M, Gupta S. The antigenic evolution of influenza: drift or thrift? Philos Trans R Soc Lond Ser B Biol Sci. 2013;368:20120200.CrossRef Wikramaratna PS, Sandeman M, Recker M, Gupta S. The antigenic evolution of influenza: drift or thrift? Philos Trans R Soc Lond Ser B Biol Sci. 2013;368:20120200.CrossRef
14.
Zurück zum Zitat Yewale V, Dharmapalan D. Complications and prognosis of influenza. In: Rao I, editor. Influenza: Complete Spectrum - II - ECAB. New Delhi: Elsevier Health Sciences; 2011. p. 1–20. Yewale V, Dharmapalan D. Complications and prognosis of influenza. In: Rao I, editor. Influenza: Complete Spectrum - II - ECAB. New Delhi: Elsevier Health Sciences; 2011. p. 1–20.
15.
Zurück zum Zitat Vander Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ. Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications. Crit Care. 2010;14:219.CrossRef Vander Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ. Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications. Crit Care. 2010;14:219.CrossRef
16.
Zurück zum Zitat Rowe HM, Meliopoulos VA, Iverson A, Bomme P, Schultz-Cherry S, Rosch JW. Direct interactions with influenza promote bacterial adherence during respiratory infections. Nat Microbiol. 2019;4:1328–36.CrossRef Rowe HM, Meliopoulos VA, Iverson A, Bomme P, Schultz-Cherry S, Rosch JW. Direct interactions with influenza promote bacterial adherence during respiratory infections. Nat Microbiol. 2019;4:1328–36.CrossRef
18.
Zurück zum Zitat Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. Current approaches for diagnosis of influenza virus infections in humans. Viruses. 2016;8:96.CrossRef Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. Current approaches for diagnosis of influenza virus infections in humans. Viruses. 2016;8:96.CrossRef
19.
Zurück zum Zitat Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009;48:S3–13.CrossRef Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009;48:S3–13.CrossRef
20.
Zurück zum Zitat Hurt AC, Chotpitayasunondh T, Cox NJ, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012;12:240–8. Hurt AC, Chotpitayasunondh T, Cox NJ, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012;12:240–8.
22.
Zurück zum Zitat Mishin VP, Patel MC, Chesnokov A, et al. Susceptibility of influenza a, B, C, and D viruses to baloxavir. Emerg Infect Dis. 2019;25:1969–72.CrossRef Mishin VP, Patel MC, Chesnokov A, et al. Susceptibility of influenza a, B, C, and D viruses to baloxavir. Emerg Infect Dis. 2019;25:1969–72.CrossRef
23.
Zurück zum Zitat Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother. 2010;54:2575–82.CrossRef Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother. 2010;54:2575–82.CrossRef
24.
Zurück zum Zitat Houser K, Subbarao K. Influenza vaccines: challenges and solutions. Cell Host Microbe. 2015;17:295–300.CrossRef Houser K, Subbarao K. Influenza vaccines: challenges and solutions. Cell Host Microbe. 2015;17:295–300.CrossRef
25.
Zurück zum Zitat Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15:17.CrossRef Sautto GA, Kirchenbaum GA, Ross TM. Towards a universal influenza vaccine: different approaches for one goal. Virol J. 2018;15:17.CrossRef
26.
Zurück zum Zitat Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68:e1–47.CrossRef Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68:e1–47.CrossRef
Metadaten
Titel
Influenza
verfasst von
Dhanya Dharmapalan
Publikationsdatum
11.02.2020
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 10/2020
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-020-03214-1

Weitere Artikel der Ausgabe 10/2020

Indian Journal of Pediatrics 10/2020 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.